Medesis Pharma SA
PAR:ALMDP
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.346
0.44
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| FR |
|
Medesis Pharma SA
PAR:ALMDP
|
1.8m EUR |
Loading...
|
|
| IN |
A
|
Aaswa Trading and Exports Ltd
BSE:512038
|
24.5T INR |
Loading...
|
|
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR |
Loading...
|
|
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
182.8B USD |
Loading...
|
|
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD |
Loading...
|
|
| US |
|
Schlumberger NV
NYSE:SLB
|
74.1B USD |
Loading...
|
|
| US |
B
|
Baker Hughes Co
NASDAQ:BKR
|
55.2B USD |
Loading...
|
|
| IN |
G
|
GTV Engineering Ltd
BSE:539479
|
4.8T INR |
Loading...
|
|
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
49.2B USD |
Loading...
|
|
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.2B CHF |
Loading...
|
|
| US |
R
|
Reddit Inc
NYSE:RDDT
|
41.7B USD |
Loading...
|
Market Distribution
| Min | -17 526.7% |
| 30th Percentile | 1.3% |
| Median | 6.1% |
| 70th Percentile | 11.5% |
| Max | 89 700% |
Other Profitability Ratios
Medesis Pharma SA
Glance View
Medesis Pharma SA operates as a clinical development stage biopharmaceutical company. The company is headquartered in Baillargues, Occitanie. The company went IPO on 2021-02-12. The firm is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
Over the last 0 months, Medesis Pharma SA’s Operating Margin has decreased from -4 397.8% to -4 397.8%. During this period, it reached a low of -4 397.8% on Jan 1, 2022 and a high of -4 397.8% on Jan 1, 2022.